New Medicaid Bulletin Articles Available as of June 30
The NC Division of Health Benefits (DHB) has recently published new Medicaid Bulletin articles:
- Velmanase Alfa-tycv for Injection, for Intravenous Use (Lamzede®) HCPCS code J3590 - Unclassified Biologics: Billing Guidelines- Effective with date of service April 4, 2023, NC Medicaid covers velmanase alfa-tycv for injection, for intravenous use (Lamzede)
- Retifanlimab-dlwr Injection, for Intravenous Use (Zynyz™) HCPCS Code J9999 - Not Otherwise Classified, Antineoplastic Drugs: Billing Guidelines- Effective with date of service April 5, 2023, NC Medicaid covers retifanlimab-dlwr injection, for intravenous use (Zynyz)
- REMINDER: Provider Resources- Where to find the latest bulletins, webinars, fact sheets and other information.
Providers are encouraged to review this information. All bulletin articles, including those related to COVID-19, are available on DHB's Medicaid Bulletin webpage.